眼表微生物源性脂磷壁酸通过诱导角膜炎症促进干眼病
该横断面研究纳入277名参与者,通过16S rRNA测序分析眼表微生物组并量化泪液脂磷壁酸(LTA)水平。发现干眼患者泪液LTA显著升高且与疾病风险和临床严重程度正相关;LTA通过TLR2和PAFR激活p38 MAPK和NF-κB通路诱导角膜炎症,PAFR拮抗剂Apafant可减轻小鼠角膜炎症并改善泪液分泌。
要点
- 干眼患者眼表微生物组LTA合成通路富集,泪液LTA水平显著升高。
- 泪液LTA与干眼疾病风险和临床严重程度呈正相关。
- LTA经TLR2和PAFR激活p38 MAPK/NF-κB通路诱导角膜炎症,Apafant可缓解。
核心结论
- 眼表微生物源性LTA通过TLR2和PAFR信号促进眼表炎症和功能障碍,与干眼病存在机制联系。
- 靶向微生物产物或其受体(如PAFR)可能为干眼病提供新治疗策略。
研究设计与样本
- 横断面研究纳入277名参与者,用16S rRNA测序分析眼表微生物组并量化泪液LTA水平。
- 体外实验使用人角膜上皮细胞(HCE-T),体内实验使用小鼠模型。
- 通过siRNA和PAFR拮抗剂Apafant评估TLR2和PAFR的作用。
主要发现
- 干眼患者眼表微生物组中LTA合成相关通路功能富集。
- 干眼患者泪液LTA水平显著升高,且与疾病风险和临床严重程度正相关。
- LTA通过TLR2和PAFR激活p38 MAPK和NF-κB信号通路,上调促炎细胞因子表达。
- 小鼠局部给予LTA诱导角膜上皮损伤、泪液分泌减少和 조직病理学改变。
- Apafant治疗显著减轻LTA诱导的角膜炎症、改善泪液分泌并保持上皮完整性。
临床怎么用
- 泪液LTA水平可能作为干眼病风险评估和严重程度判断的潜在生物标志物。
- PAFR拮抗剂(如Apafant)可能成为干眼病抗炎治疗的新选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Ocular surface microbiota (OSM) dysbiosis is associated with dry eye disease (DED), but the underlying mechanisms remain poorly understood. This study investigated the role of lipoteichoic acid (LTA), a Gram-positive bacterial product, in DED pathogenesis. METHODS: A cross-sectional study was conducted involving 277 participants to analyze OSM composition via 16S rRNA sequencing and quantify tear LTA levels. In vitro experiments using human corneal epithelial cells (HCE-T) and in vivo mouse models were used to explore LTA-induced inflammation. The involvement of Toll-like receptor 2 (TLR2) and platelet-activating factor receptor (PAFR) was assessed using siRNAs and the PAFR antagonist Apafant. RESULTS: Patients with DED showed functional enrichment in LTA synthesis-related pathways in their OSM. Tear LTA levels were significantly elevated in patients with DED and correlated positively with disease risk and clinical severity. Mechanistically, LTA activated p38 MAPK and NF-κB signaling pathways via TLR2 and PAFR, upregulating pro-inflammatory cytokine expression. In mice, topical LTA administration induced corneal epithelial damage, reduced tear secretion, and caused histopathological changes. Treatment with Apafant significantly alleviated LTA-induced corneal inflammation, improved tear secretion, and preserved epithelial integrity. CONCLUSIONS: Our findings establish a mechanistic link between OSM-derived LTA and DED. LTA promotes ocular surface inflammation and dysfunction through TLR2 and PAFR signaling, suggesting that targeting microbial products or their receptors, such as PAFR, may offer a novel therapeutic strategy for DED.
引用
- An Q, Qin X, Zhong L, et al. Ocular Surface Microbiota-Derived Lipoteichoic Acid Promotes Dry Eye Disease by Inducing Corneal Inflammation. Invest Ophthalmol Vis Sci. 2026. PMID: 41873899. doi:10.1167/iovs.67.3.50
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。